Catalent (CTLT) Appoints Uwe Röhrhoff To Its Board Of Directors
11/1/2016 11:40:09 AM
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced that it has added Uwe Röhrhoff as an independent member of its Board of Directors, effective at the next regularly scheduled meeting of its Board. The appointment follows the resignations of Chinh Chu and E. Bruce McEvoy, the designees of its former equity sponsor The Blackstone Group, L.P., after the sale of Blackstone’s interest in the Company.
comments powered by